Gemcitabina Hikma

Gemcitabine is a chemotherapy drug used to treat various cancers. This intravenous medication is manufactured by Hikma Farmacêutica (Portugal), S.A. and is part of cancer treatment protocols.

Gemcitabine is primarily used in the treatment of various types of cancer. It works by interfering with the growth and spread of cancer cells in the body. This medication is often administered intravenously as part of a broader cancer treatment plan.

Common effects of Gemcitabine may include fatigue, nausea, and a decreased ability to fight infections. Some patients may also experience hair loss and changes in appetite. These effects can vary widely among individuals.

Gemcitabine should be handled with care, as it is a potent chemotherapy agent. It is important to follow the advice of healthcare professionals regarding its use. Proper storage and administration are crucial to ensure safety and effectiveness.

Gemcitabine may interact with other medications, including those that suppress the immune system or affect blood cell production. It is important to discuss all current medications with a healthcare provider before starting Gemcitabine treatment.